Global Colorectal Cancer Diagnostics Market To Reach a Value of US$ 2,000 Mn by 2022-end

Recently, a novel report developed using proven research methodologies at the headquarters of Fact. MR has identified various prominent factors and trends prompting market growth ofColorectal Cancer Diagnostics Market. The study is titled as “Colorectal Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022”, which deeply analyses the global market trends, with historical data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) during the mentioned forecast of 2017-2022. For the benefit of the readers, the report concludes with a special focus on the detailed profiles of the major vendors in the globalcolorectal cancer diagnostics market.

Request For Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=70

Colorectal cancer diagnosticsare a wide range of screening tests and diagnosis procedures that are employed before treating a patient with colon cancer. A typical diagnosis of colorectal cancer consists of tests such as colonoscopy, biopsy, blood sample testing, CT scan, ultrasound, MRI and molecular testing of the growing tumor.

A recent report by Fact.MR projects the global colorectal cancer diagnostics market to register an impressive expansion at 8.5% CAGR during the forecast period 2017 to 2022. Revenues from the global colorectal cancer diagnostics market is expected to surpass US$ 2,000 Mn by 2022-end.

Surging Unmet Requirements for Colorectal Cancer Diagnostics in Emerging Economies to Pave Growth Opportunities for Market Players

The emergence of new improved diagnosis tests, soaring uptakes of diagnosis-associated therapies, and increasing initiatives by private and government organisations are factors likely to fuel growth of the global colorectal cancer diagnostics market. Surging unmet requirements for colorectal cancer diagnostics around many emerging economies, along with the shortage of neoadjuvant as well as adjuvant pipeline agents for diagnosing high-risk patients suffering from resectable colorectal cancer is anticipated to pave tremendous growth opportunities for global leaders in the market. In contrast, factors such as rising patient reluctance against medications of colorectal cancer, and absence of awareness about therapeutics and diagnostics of colorectal cancer in many remote regions around the world is estimated to impede the market growth.

FOB Tests will Continue to Witness Largest Adoption for Colorectal Cancer Diagnostics

FOB tests will remain the largest adopted tests for colorectal cancer diagnostics across the globe. In addition, FOB tests in the global colorectal cancer diagnostics market will account for the largest revenues, followed by CTC tests. The immunochemistry tests will register the highest CAGR in the market through 2022. However, BRAF tests will account for the lowest revenues in the global market for colorectal cancer diagnostics throughout the forecast period.

Based on end-users, even though hospital-associated labs are estimated to remain sought-after for colorectal cancer diagnostics, cancer research institutes will register the fastest expansion through 2022. Hospital-associated labs in the global colorectal cancer diagnostics market are estimated to account for nearly US$ 1,000 Mn in revenues by 2022-end. In addition, independent diagnostic laboratories will remain the second largest end-users of colorectal cancer diagnostics in the global market.

Competition Tracking

The report has also profiled prominent players in the global market for colorectal cancer diagnostics, which include Illumina, Inc, Sysmex Corporation, Danaher Corporation, Rosetta Genomics, Epigenomics AG, Exact Science Corporation, Pathway Genomics Corporation, Biocept, Inc., Cancer Genetics, Inc, and Foundation Medicine, Inc

Browse Full Report with TOC @https://www.factmr.com/report/70/colorectal-cancer-diagnostics-market

Table of Content

1. Global Colorectal Cancer Diagnostics Market - Executive Summary

2. Global Colorectal Cancer Diagnostics Market Overview
2.1. Introduction
2.1.1. Global Colorectal Cancer Diagnostics Market Taxonomy
2.1.2. Global Colorectal Cancer Diagnostics Market Definition
2.2. Global Colorectal Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Colorectal Cancer Diagnostics Market Y-o-Y Growth
2.3. Global Colorectal Cancer Diagnostics Market Dynamics
2.3.1. Drivers
2.3.2. Restraints
2.3.3. Trends
2.4. Supply Chain
2.5. Epidemiology
2.6. List of Distributors
2.7. Average Pricing Analysis
2.8. Regulations
2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Colorectal Cancer Diagnostics Market Analysis and Forecast By Test Type
3.1. Global Colorectal Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022
3.1.1. FOB Colorectal Cancer Diagnostics Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. CTC Tests Colorectal Cancer Diagnostics Market Size and Forecast, 2012-2022
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region

Continue…@@

Check Discount @ https://www.factmr.com/connectus/sample?flag=D&rep_id=70

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare Market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/Follow us on LinkedIn: https://www.linkedin.com/company/factmr

This release was published on openPR.